Unknown

Dataset Information

0

Preliminary results of the Phase IIa trial of a folate binding protein (FBP) adjuvant cancer vaccine (E39+GM-CSF) in ovarian and endometrial cancer patients to prevent recurrence

ABSTRACT:

SUBMITTER: Greene J 

PROVIDER: S-EPMC4288735 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients.
| S-EPMC5362533 | biostudies-literature
Unknown Biological Effects of Anti-Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Antibody Formation in Patients Treated With GM-CSF (Sargramostim) as Adjuvant Therapy of Melanoma.
| S-EPMC4385005 | biostudies-literature
Unknown Immune Evasion of G-CSF and GM-CSF in Lung Cancer.
| S-EPMC10758314 | biostudies-literature
Unknown Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages.
| S-EPMC10253671 | biostudies-literature
Unknown Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders.
| S-EPMC9850113 | biostudies-literature
Unknown GM-CSF: A Double-Edged Sword in Cancer Immunotherapy.
| S-EPMC9294178 | biostudies-literature
Unknown GM-CSF-Dependent Inflammatory Pathways.
| S-EPMC6737278 | biostudies-literature
Unknown GM-CSF Mediates Mesenchymal-Epithelial Cross-talk in Pancreatic Cancer.
| S-EPMC5549011 | biostudies-literature
Unknown The mechanism of GM-CSF inhibition by human GM-CSF auto-antibodies suggests novel therapeutic opportunities.
| S-EPMC6204844 | biostudies-literature
Unknown Recurrence Features and Factors influencing Post-relapse Survival in Early-stage Endometrial Cancer after Adjuvant Radiotherapy.
| S-EPMC8692693 | biostudies-literature